Associations between HLA Class II- DRB1 Alleles with susceptibility to Viral Hepatitis B and C in patients with HIV infection

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Occult HBV infection and two clinical cases with malignant comorbidities

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Randomized control trial of home-based Hepatitis C self-testing in key populations in Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Prevalence of Hepatitis among the general population in Botswana from the STI microbial survey of 2017/2018

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Simplified ART regime on the background of multi-allergy in an elderly HIV-infected patient

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Key Considerations for the Introduction of Hepatitis B Birth Dose Vaccine in Cameroon

Conference on Liver Disease in Africa (COLDA) 2021

A Community of Practice for the Introduction and Scale-up of Hepatitis B Birth Dose Vaccination in Africa: Challenges, Opportunities, and Lessons Learned

Conference on Liver Disease in Africa (COLDA) 2021

Hépatite Delta au Senegal

Conference on Liver Disease in Africa (COLDA) 2021

Long Term Follow up of Chronic Hepatitis B Cohort in Africa; The Prolifica Gambia Exprience

Conference on Liver Disease in Africa (COLDA) 2021

Assessment of Fibrosis Markers in HEPSANET: A Collaborative Network of Hepatitis B Cohorts in Sub-Saharan Africa

Conference on Liver Disease in Africa (COLDA) 2021

Age Cohort Screening for Hepatocellular Carcinoma in an African Population

Conference on Liver Disease in Africa (COLDA) 2021

Velpatasvir-Based Regimens in Treatment-Naïve and Treatment-Experienced Adults with Resistant Hepatitis C Virus Genotype 4 Subtypes Endemic to Sub-Saharan Africa: Findings from the SHARED-3 Study in Rwanda

Conference on Liver Disease in Africa (COLDA) 2021

Values and Preferences for Hepatitis C Self-Testing Among the General Population and Healthcare Workers in Rwanda

Conference on Liver Disease in Africa (COLDA) 2021

EILF-Italian Migrants Study: an HCV and HBV Micro Elimination Pilot Project

Conference on Liver Disease in Africa (COLDA) 2021

Genedrive® Point of Care Qualitative Testing in a Pilot Hepatitis C Treatment Program

Conference on Liver Disease in Africa (COLDA) 2021

"Have a Heart, Save My Liver! Who Has Access to the Cure in Africa?"

Conference on Liver Disease in Africa (COLDA) 2021

Challenges Facing Hepatitis B Infected Population During the COVID-19 Crisis: An Egyptian Survey-Based Questionnaire Study Research

Conference on Liver Disease in Africa (COLDA) 2021

Reduced Hepatitis Screening During Lockdown, a Threat to Global Hepatitis Elimination Target

Conference on Liver Disease in Africa (COLDA) 2021

Impacts de la COVID-19 sur la Prévention, les Soins et le Traitement de L’Hépatite, du VIH et de la Syphilis Chez les Femmes Enceintes dans le District Sanitaire de Baskuy à Ouagadougou

Conference on Liver Disease in Africa (COLDA) 2021

Nonalcoholic Fatty Liver Disease and Severity of COVID-19 Disease Depending on the Plasminogen Activator Inhibitor -1-675 Gene Polymorphism

Conference on Liver Disease in Africa (COLDA) 2021

COVID-19 Resilience at Livewell Initiative LWI

Conference on Liver Disease in Africa (COLDA) 2021

A Cross-Sectional Study of Gastrointestinal Manifestations in COVID-19 Egyptian Patients.

Conference on Liver Disease in Africa (COLDA) 2021

Acceptability of the Plasma Separation Card for Sample Collection to Screen for Viral Hepatitis Among People Attending an HIV Clinic in Kampala, Uganda

Conference on Liver Disease in Africa (COLDA) 2021

A Correlation Study of Liver Biopsy Appearances, Serum HBV DNA and HBSAG Quantification Levels of Chronic Liver Disease Patients at Oauthc, ILE-IFE

Conference on Liver Disease in Africa (COLDA) 2021